Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis

Annals of Neurology

Volumn 69, Issue 2, 2011, Pages 418-422

  Higuchi, Osamu ^a   Hamuro, Johko ^a   Motomura, Masakatsu ^b   Yamanashi, Yuji ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CHOLINERGIC RECEPTOR ANTIBODY; IMMUNOGLOBULIN G1; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 4 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CELL STRAIN HEK293; COMPLEMENT SYSTEM; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; LIGAND BINDING; MAJOR CLINICAL STUDY; MALE; MOLECULAR RECOGNITION; MYASTHENIA GRAVIS; PRIORITY JOURNAL; PROTEIN FUNCTION;

AUTOANTIBODIES; HUMANS; IMMUNOGLOBULIN G; LDL-RECEPTOR RELATED PROTEINS; MYASTHENIA GRAVIS; RADIOIMMUNOPRECIPITATION ASSAY; RECEPTORS, CHOLINERGIC;

EID: 79952513213     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22312     Document Type: Article

References (18)

1. Sanes JR, Lichtman JW., Induction, assembly, maturation and maintenance of a postsynaptic apparatus. Nat Rev Neurosci 2001; 2: 791-805. (Pubitemid 33674061)
2. Weatherbee SD, Anderson KV, Niswander LA., LDL-receptor-related protein 4 is crucial for formation of the neuromuscular junction. Development 2006; 133: 4993-5000. (Pubitemid 46085064)
3. Kim N, Stiegler AL, Cameron TO, et al. Lrp4 is a receptor for agrin and forms a complex with MuSK. Cell 2008; 135: 334-342.
4. Zhang B, Luo S, Wang Q, et al. LRP4 serves as a coreceptor of agrin. Neuron 2008; 60: 285-297.
5. Vincent A., Unravelling the pathogenesis of myasthenia gravis. Nat Rev Immunol 2002; 2: 797-804. (Pubitemid 37328719)
6. Almon RR, Andrew CG, Appel SH., Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors. Science 1974; 186: 55-57.
7. Lindstrom JM, Seybold ME, Lennon VA, et al. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology 1976; 26: 1054-1059.
8. Toyka KV, Brachman DB, Pestronk A, et al. Myasthenia gravis: passive transfer from man to mouse. Science 1975; 190: 397-399.
9. Engel AG, Lambert EH, Howard FM,. Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations. Mayo Clin Proc 1977; 52: 267-280. (Pubitemid 8113467)
10. Hoch W, McConville J, Helms S, et al. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 2001; 7: 365-368. (Pubitemid 32224355)
11. McConville J, Farrugia ME, Beeson D, et al. Detection and characterization of MuSK antibodies in seronegative myasthenia gravis. Ann Neurol 2004; 55: 580-584. (Pubitemid 38391977)
12. Vincent A, Leite MI., Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis. Curr Opin Neurol 2005; 18: 519-525. (Pubitemid 41476137)
13. Matthews I, Chen S, Hewer R, et al. Muscle-specific receptor tyrosine kinase autoantibodies-a new immunoprecipitation assay. Clin Chim Acta 2004; 348: 95-99. (Pubitemid 39209006)
14. Tannous BA, Kim DE, Fernandez JL, et al. Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol Ther 2005; 11: 435-443. (Pubitemid 40277320)
15. Jaretzki A III, Barohn RJ, Ernstoff RM, et al. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 2000; 55: 16-23.
16. Newsom-Davis J., Lambert-Eaton myasthenic syndrome. Rev Neurol (Paris) 2004; 160: 177-180. (Pubitemid 38325734)
17. Vernino S, Lennon VA., Autoantibody profiles and neurological correlations of thymoma. Clin Cancer Res 2004; 10: 7270-7275. (Pubitemid 39487714)
18. Leite MI, Jacob S, Viegas S, et al. IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis. Brain 2008; 131: 1940-1952. (Pubitemid 351957451)